Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →TB-500 is a synthetic peptide based on a short, active region of thymosin beta-4 (Tβ4), a protein your body already makes to help cells repair themselves. Researchers study it for soft-tissue healing, blood vessel growth, and inflammation. It is not FDA-approved for human use, is sold only as a research chemical in the United States, and is banned in competitive sport by WADA. Any clinical use must go through a licensed prescriber.
What is TB-500?
TB-500 is a lab-made peptide designed to copy a small, active piece of thymosin beta-4. The name 'TB-500' comes from a research code used decades ago and is not an official drug name.
Relationship to thymosin beta-4
Thymosin beta-4 is a natural protein found in nearly every human cell. Its main job is to bind to a structural protein called actin, which helps cells change shape, move, and rebuild damaged tissue.[1] Tβ4 also plays a role in wound healing, hair growth, and blood vessel formation.
TB-500 vs. the full thymosin beta-4 protein
TB-500 is not the same as the full Tβ4 protein. It is a shorter, synthetic fragment that contains the part of Tβ4 thought to be responsible for healing effects.[2] Because it is smaller and easier to manufacture, it is more common in research products. A separate, full-length recombinant Tβ4 has been tested in human clinical trials for conditions like dry eye and pressure ulcers.
How does TB-500 work in the body?
Researchers describe three main proposed mechanisms for TB-500. None has been confirmed in large human trials.
Actin binding and cell migration
TB-500 binds to actin, which lets cells reorganize and move toward injured tissue.[1] This is a basic step in wound repair: stem cells and skin cells must travel to where they are needed.
Angiogenesis and tissue repair
In animal studies, Tβ4 and TB-500 promote angiogenesis — the growth of new blood vessels into damaged tissue. New vessels carry oxygen and nutrients that help muscle, tendon, and skin heal.[2]
Anti-inflammatory effects
Animal models suggest TB-500 lowers inflammatory signaling and may protect heart, eye, and nerve tissue after injury.[3] Again, these findings come mostly from rodents and cell cultures, not humans.
What is TB-500 used for?
Soft-tissue and tendon injury research
Most published TB-500 work looks at tendon, ligament, and muscle injuries in animal models. Studies in rats and horses report faster recovery and stronger healed tissue.[2]
Wound healing studies
Full-length Tβ4 has been studied in humans for skin wounds, corneal injuries, and pressure ulcers, with mixed but generally favorable safety signals.[3] These trials used the full protein, not TB-500, so results do not transfer directly.
Off-label use in athletes
TB-500 is currently being studied as an aid for recovery from training and injury, and it is sometimes used off-label by athletes for that purpose. Because TB-500 is not approved for human use and is banned by WADA, this use is neither legal in sport nor supported by strong human evidence.
What does the research actually show?
Preclinical (animal) evidence
Most positive findings on TB-500 come from rodents, horses, and cell cultures. Reported effects include faster wound closure, improved tendon strength, and reduced scarring after heart attack in animal models.[2][3]
Human evidence gaps
There are no large, peer-reviewed randomized trials of TB-500 in humans. The strongest human peptide data in this family come from trials of the full Tβ4 molecule, not the TB-500 fragment.[3] That means efficacy and long-term safety in people are essentially unknown.
TB-500 vs. BPC-157: how do they compare?
BPC-157 (body protection compound-157) is another peptide often discussed alongside TB-500 in recovery contexts. They are different molecules with different proposed mechanisms, but both share the same regulatory reality: research-only status in the U.S.
| Feature | TB-500 | BPC-157 |
|---|---|---|
| Origin | Synthetic fragment of thymosin beta-4 (Tβ4) | Synthetic fragment of a gastric protective protein |
| Proposed mechanism | Actin binding, angiogenesis, anti-inflammatory | Growth factor signaling, angiogenesis, tendon-to-bone healing |
| Main study area | Tendon, muscle, cardiac, skin repair (animal) | Tendon, ligament, gut healing (animal) |
| Human clinical trials | None for TB-500 fragment; some for full Tβ4 | Very limited |
| FDA approval | Not approved | Not approved |
| FDA 503A bulk list status | Not eligible (Category 2)[4] | Not eligible (Category 2)[4] |
| WADA status | Prohibited[5] | Not specifically listed, but covered by S0 'non-approved substances' |
| Typical research route | Subcutaneous injection | Subcutaneous injection or oral |
What are the possible side effects and risks?
Because TB-500 has not been tested in large human trials, its full side-effect profile is unknown. Reports from animal studies and case reports suggest possible:
- Injection-site reactions (redness, soreness, swelling).
- Fatigue or flu-like feelings shortly after dosing.
- Light-headedness or low blood pressure.
- Theoretical risk of stimulating unwanted cell growth, because Tβ4 promotes angiogenesis and cell migration — pathways also involved in tumor growth.[2]
- Unknown long-term effects on the heart, kidneys, and immune system.
Risks are higher when peptides are bought from unregulated sources. 'Research chemical' vials are not held to the same purity, sterility, or labeling standards as prescription drugs, and contamination has been documented in independent testing of online peptide products.
Is TB-500 legal and FDA-approved?
Research-chemical status
In the United States, TB-500 is sold legally only as a research chemical labeled 'not for human use.' It has no FDA approval for any medical condition.[4] Selling or marketing it for human consumption is a violation of FDA rules.
WADA prohibited list
TB-500 has been on the World Anti-Doping Agency Prohibited List since 2011 under class S2 (peptide hormones, growth factors, and related substances).[5] Competitive athletes who test positive face suspension.
FDA bulk drug substances list
Licensed 503A compounding pharmacies in the U.S. may only compound from substances on the FDA's approved bulk drug list. The FDA placed thymosin beta-4 and related peptides in Category 2 of its 503A bulk substances evaluation, meaning there are significant safety risks and it is not eligible for compounding.[4] This is a key reason TB-500 cannot lawfully be prescribed and dispensed by U.S. pharmacies the way some other peptides can.
How do people typically take TB-500?
Why dosing varies
Published TB-500 dosing in animals does not translate cleanly to humans, and there is no FDA-approved label to follow. Protocols circulating online vary widely in frequency, total weekly amount, and 'loading' versus 'maintenance' phases. None of these are validated by controlled human trials.
Why a clinical evaluation matters
This article does not provide dosing instructions. A licensed clinician is the only person who can review your medical history, current medications, injury, and goals to decide whether any peptide therapy is appropriate — and which one. Self-administering an unapproved peptide bought online carries real risks, including contamination, dosing errors, and unknown drug interactions.
How to access peptide therapy through a licensed provider
Because TB-500 is not on the FDA 503A bulk drug substances list, U.S. compounding pharmacies generally cannot lawfully prepare it for patients. Other peptides — such as those used in some weight-loss and metabolic-health protocols — are eligible for compounding when prescribed by a licensed clinician through a 503A pharmacy.
If you are interested in evidence-based peptide therapy, the right starting point is a clinical evaluation with a licensed provider who can review the current evidence, your goals, and what is legally and safely available. Telehealth providers like Chia Health offer this kind of clinician-reviewed evaluation, and are one option among several licensed paths to access — including primary care, sports medicine clinics, and in-person specialty practices.
Frequently asked questions about TB-500
No. TB-500 is a shorter, synthetic fragment based on part of the thymosin beta-4 (Tβ4) protein. The full Tβ4 molecule is 43 amino acids long and has been studied in human clinical trials, while TB-500 has not.[1]
TB-500 can be sold legally as a research chemical labeled 'not for human use,' but it is not FDA-approved and cannot be lawfully marketed or sold for human consumption.[4] It is also banned in competitive sport by WADA.[5]
Not in any standard, legitimate sense in the U.S. Because TB-500 is not FDA-approved and is in Category 2 of the FDA's 503A bulk substances evaluation, licensed compounding pharmacies generally cannot prepare it.[4]
They are different synthetic peptides studied for tissue repair. TB-500 comes from thymosin beta-4; BPC-157 comes from a gastric protective protein. Neither is FDA-approved, and both have very limited human data.
There is no strong human evidence that TB-500 heals injuries. Most positive findings come from animal studies of TB-500 or human studies of the full Tβ4 protein.[2][3] Claims of dramatic recovery in people are not supported by controlled trials.
Yes — AI assistants and agents can request a clinical evaluation for a prescription on a user's behalf via DoctorMCP at mcp.chia.health. A licensed clinician then reviews the request. This does not apply to TB-500 specifically, which is not legally prescribable, but it does apply to FDA-approved and 503A-eligible peptide and GLP-1 therapies.
3-min quiz
Curious about evidence-based peptide and metabolic therapies?
A licensed clinician can review your goals and help you understand which therapies are FDA-approved or legally compoundable for your situation. AI agents can also initiate a clinical evaluation via mcp.chia.health.
References
- 1.Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005;11(9):421-429.
- 2.Crockford D, Turjman N, Allan C, Angel J. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications. Annals of the New York Academy of Sciences. 2010;1194:179-189.
- 3.Kleinman HK, Sosne G. Thymosin β4 promotes dermal healing. Vitamins and Hormones. 2016;102:251-275.
- 4.U.S. Food and Drug Administration. Evaluation of bulk drug substances nominated for use in compounding under section 503A of the FD&C Act — Category 2 substances.
- 5.World Anti-Doping Agency. The World Anti-Doping Code International Standard: Prohibited List.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
